SI1924585T1 - Nova kristalinična oblika piridazino (4,5-b) indolnega derivata - Google Patents

Nova kristalinična oblika piridazino (4,5-b) indolnega derivata

Info

Publication number
SI1924585T1
SI1924585T1 SI200631252T SI200631252T SI1924585T1 SI 1924585 T1 SI1924585 T1 SI 1924585T1 SI 200631252 T SI200631252 T SI 200631252T SI 200631252 T SI200631252 T SI 200631252T SI 1924585 T1 SI1924585 T1 SI 1924585T1
Authority
SI
Slovenia
Prior art keywords
pyridazino
crystalline form
novel crystalline
indole derivative
indole
Prior art date
Application number
SI200631252T
Other languages
English (en)
Inventor
William L Rocco
John D Higgins
Original Assignee
Sanofi Aventis Us Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37546937&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI1924585(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Aventis Us Llc filed Critical Sanofi Aventis Us Llc
Publication of SI1924585T1 publication Critical patent/SI1924585T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Psychiatry (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
SI200631252T 2005-08-29 2006-08-24 Nova kristalinična oblika piridazino (4,5-b) indolnega derivata SI1924585T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US71215305P 2005-08-29 2005-08-29
PCT/US2006/033254 WO2007027525A1 (en) 2005-08-29 2006-08-24 Novel crystalline form of a pyridazino [4 , 5-b] indole derivative
EP06813757A EP1924585B1 (en) 2005-08-29 2006-08-24 Novel crystalline form of a pyridazino [4 , 5-b] indole derivative

Publications (1)

Publication Number Publication Date
SI1924585T1 true SI1924585T1 (sl) 2012-09-28

Family

ID=37546937

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200631252T SI1924585T1 (sl) 2005-08-29 2006-08-24 Nova kristalinična oblika piridazino (4,5-b) indolnega derivata

Country Status (32)

Country Link
US (1) US7683062B2 (sl)
EP (1) EP1924585B1 (sl)
JP (1) JP5063600B2 (sl)
KR (2) KR20080050577A (sl)
CN (1) CN101253176B (sl)
AR (1) AR057099A1 (sl)
AT (1) ATE531717T1 (sl)
AU (1) AU2006285142B2 (sl)
BR (1) BRPI0615259A2 (sl)
CA (1) CA2619284C (sl)
CR (1) CR9723A (sl)
CY (1) CY1112317T1 (sl)
DK (1) DK1924585T3 (sl)
EA (1) EA014164B1 (sl)
EC (1) ECSP088209A (sl)
ES (1) ES2375841T3 (sl)
HK (1) HK1123794A1 (sl)
HR (1) HRP20120073T1 (sl)
IL (1) IL189276A (sl)
MA (1) MA30000B1 (sl)
NO (1) NO20081365L (sl)
NZ (1) NZ566087A (sl)
PL (1) PL1924585T3 (sl)
PT (1) PT1924585E (sl)
RS (1) RS52318B (sl)
SI (1) SI1924585T1 (sl)
TN (1) TNSN08059A1 (sl)
TW (1) TW200813060A (sl)
UA (1) UA91716C2 (sl)
UY (1) UY29771A1 (sl)
WO (1) WO2007027525A1 (sl)
ZA (1) ZA200801890B (sl)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2755334T3 (es) * 2003-11-17 2020-04-22 Merck & Cie Proceso para la preparación de formas cristalinas B de clorhidrato de (6R)-L-eritro-tetrahidrobiopterina a partir de otras formas cristalinas
EP1776365B1 (en) * 2004-06-02 2011-08-03 Sandoz Ag Meropenem intermediate in crystalline form
KR101314158B1 (ko) * 2005-09-21 2013-10-04 4에스체 악티엔게젤샤프트 히스톤 탈아세틸 효소 억제제로서의 설포닐피롤 염산염
WO2007053427A2 (en) * 2005-10-31 2007-05-10 Janssen Pharmaceutica N.V. Novel processes for the preparation of piperazinyl and diazapanyl benzamide derivatives
EA016054B1 (ru) * 2006-06-16 2012-01-30 Х. Лундбекк А/С Кристаллические формы 4-[2-(4-метилфенилсульфанил)фенил] пиперидина с объединенным ингибированием повторного поглощения серотонина и норадреналина для лечения невропатической боли
AU2007318132B2 (en) * 2006-10-27 2012-11-08 Signal Pharmaceuticals, Llc Solid forms comprising 4-[9-(tetrahydro-furan-3-yl)-8-(2,4,6-trifluoro-phenylamino)-9H-purin-2-ylamino]-cyclohexan-1-ol, compositions thereof, and use therewith
EP2085397A1 (en) * 2008-01-21 2009-08-05 Esteve Quimica, S.A. Crystalline form of abacavir
US7935817B2 (en) * 2008-03-31 2011-05-03 Apotex Pharmachem Inc. Salt form and cocrystals of adefovir dipivoxil and processes for preparation thereof
AR071318A1 (es) * 2008-04-15 2010-06-09 Basilea Pharmaceutica Ag Benzhidril ester del acido (6r,7r)-7-{2-(5-amino-[1,2,4]tiadiazol-3-il)-2-[(z)-tritiloxiimino]-acetilamino}-3-[(r)-1'-terc-butoxicarbonil-2-oxo-[1,3']bipirrolidinil-(3e)-ilidenometil]-8-oxo-5-tia-1-aza-biciclo[4.2.0]oct-2-eno-2-carboxilico cristalino; su elaboracion y uso
US8097719B2 (en) * 2008-07-15 2012-01-17 Genesen Labs Meropenem intermediate in novel crystalline form and a method of manufacture of meropenem
RU2011110241A (ru) * 2008-08-18 2012-09-27 САНОФИ-АВЕНТИС Ю.Эс. ЭлЭлСи (US) СПОСОБ ПОЛУЧЕНИЯ ПОЛИМОРФА 7-ХЛОР-N,N,5-ТРИМЕТИЛ-4-ОКСО-3-ФЕНИЛ-3,5-ДИГИДРО-4Н-ПИРИДАЗИНО[4,5-b]ИНДОЛ-1-АЦЕТАМИДА
RU2545456C2 (ru) 2010-03-12 2015-03-27 Омерос Корпорейшн Pde10 ингибиторы и содержащие их композиции и способы
CA2808904A1 (en) * 2010-09-01 2012-03-08 Arena Pharmaceuticals, Inc. Non-hygroscopic salts of 5-ht2c agonists
EP2760859A1 (en) * 2011-09-30 2014-08-06 Sunshine Lake Pharma Co., Ltd Crystalline forms of azilsartan and preparation and uses thereof
NZ630803A (en) * 2014-04-28 2016-03-31 Omeros Corp Optically active pde10 inhibitor
NZ630810A (en) 2014-04-28 2016-03-31 Omeros Corp Processes and intermediates for the preparation of a pde10 inhibitor
JP2018513153A (ja) 2015-04-24 2018-05-24 オメロス コーポレーション Ｐｄｅ１０インヒビターならびに関連する組成物および方法
US9920045B2 (en) 2015-11-04 2018-03-20 Omeros Corporation Solid state forms of a PDE10 inhibitor
CN111303230B (zh) * 2020-03-09 2021-07-13 中国食品药品检定研究院 一种黄体酮共晶物及其制备方法和用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2766823B1 (fr) * 1997-07-30 1999-10-08 Synthelabo Derives de 4-oxo-3,5-dihydro-4h-pyridazino[4,5-b] indole-1-acetamide, leur preparation et leur application en therapeutique
FR2788696B1 (fr) 1999-01-26 2004-03-05 Synthelabo Utilisation de derives de pyridazino [4,5-b] indole-1-acetamide pour la preparation de medicaments destines aux maladies du systeme nerveux central
FR2829939B3 (fr) 2001-09-21 2003-11-28 Sanofi Synthelabo Utilisation du 7-chloro-n,n,5-trimethyl-4-oxo-3-phenyl-3,5- dihydro-4h-pyridazino(4,5-b)indole-1-acetamide pour la preparation de medicaments destines au traitement de la polyarthrite rhumatoide
WO2005034999A2 (en) 2003-10-10 2005-04-21 Bvm Holding Co. Composition comprising association complex of a pharmaceutical and a poloxamer

Also Published As

Publication number Publication date
MA30000B1 (fr) 2008-12-01
PT1924585E (pt) 2012-01-19
HRP20120073T1 (hr) 2012-07-31
JP2009506116A (ja) 2009-02-12
EA014164B1 (ru) 2010-10-29
ZA200801890B (en) 2009-11-25
CY1112317T1 (el) 2015-12-09
PL1924585T3 (pl) 2012-08-31
CN101253176B (zh) 2012-04-18
CN101253176A (zh) 2008-08-27
AU2006285142A1 (en) 2007-03-08
ES2375841T3 (es) 2012-03-06
US20080139569A1 (en) 2008-06-12
AU2006285142B2 (en) 2012-06-14
JP5063600B2 (ja) 2012-10-31
WO2007027525A1 (en) 2007-03-08
ECSP088209A (es) 2008-06-30
NO20081365L (no) 2008-04-03
UA91716C2 (ru) 2010-08-25
EA200800716A1 (ru) 2008-08-29
HK1123794A1 (en) 2009-06-26
CR9723A (es) 2008-06-18
KR20080050577A (ko) 2008-06-09
CA2619284C (en) 2014-04-29
RS52318B (en) 2012-12-31
TW200813060A (en) 2008-03-16
UY29771A1 (es) 2007-03-30
TNSN08059A1 (en) 2009-07-14
KR20130087059A (ko) 2013-08-05
CA2619284A1 (en) 2007-03-08
US7683062B2 (en) 2010-03-23
IL189276A (en) 2012-07-31
BRPI0615259A2 (pt) 2011-05-17
IL189276A0 (en) 2008-08-07
EP1924585A1 (en) 2008-05-28
ATE531717T1 (de) 2011-11-15
AR057099A1 (es) 2007-11-14
DK1924585T3 (da) 2012-02-27
NZ566087A (en) 2011-03-31
EP1924585B1 (en) 2011-11-02

Similar Documents

Publication Publication Date Title
SI1924585T1 (sl) Nova kristalinična oblika piridazino (4,5-b) indolnega derivata
EP1935890A4 (en) SUBSTITUTED INDOLE DERIVATIVE IN POSITION 2 BY A HETEROARYL GROUP
IL178940A0 (en) Indole derivative having piperidine ring
EP1931632A4 (en) USEFUL INDOOR CONNECTIONS
EP1942105B8 (en) Aminodihydrothiazine derivative
AU2006308449A8 (en) Trazodone composition for once a day administration
IL188039A0 (en) Oxindole derivatives
IL191846A0 (en) Substituted imidazoquinolines imidazonaphthyridines, and imidazopyridines, compositions, and methods
IL191768A0 (en) Novel fused pyrrole derivatives
EP1748048A4 (en) IMIDAZOPYRIDINE COMPOUND
IL186669A0 (en) Acetylene derivatives
AU2006241684A1 (en) Novel lactam compound
HK1122797A1 (en) Derivatives of pyrido
IL185470A0 (en) Novel salt of quinuclidine derivative
IL188371A0 (en) Novel piperidine derivatives
IL178774A0 (en) Imidazopyridine compound
HK1110079A1 (en) Imidazopyridine derivative
EP1880995A4 (en) METHOD OF SYNTHESIZING AN INDOLE DERIVATIVE COMPRISING A PIPERIDINE CYCLE
GB0506967D0 (en) Novel crystalline salt
TWI365186B (en) Indole derivatives
ZA200802989B (en) Naphthyridin derivatives
ZA200806859B (en) Novel crystalline compounds
EP1951257A4 (en) CRYSTALLINE FORMS
ZA200709230B (en) Novel piperidine derivatives
IL191546A0 (en) Process for the preparation of purified crystalline cci-779